A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells

Journal of Immunology

Volumn 162, Issue 3, 1999, Pages 1723-1729

  Groux, Hervé ^a,b   Cottrez, Fraņoise ^a   Rouleau, Matthieu ^a   Mauze, Smita ^a   Antonenko, Svetlana ^a   Hurst, Stephen ^a   McNeil, Tom ^a   Bigler, Mike ^a   Roncarolo, Maria Grazia ^a,c   Coffman, Robert L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; IMMUNOREGULATION; LEISHMANIA MAJOR; LISTERIA MONOCYTOGENES; LISTERIOSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOCYTOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR REJECTION;

ANIMALS; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; BASE SEQUENCE; DNA PRIMERS; HUMANS; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-10; LEISHMANIA MAJOR; LISTERIA MONOCYTOGENES; LYMPHOCYTE ACTIVATION; MAST-CELL SARCOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; MONOCYTES; OVALBUMIN; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; UP-REGULATION;

EID: 0033083947     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. de Vries, J. E., and R. de Waal Melefyt. 1995. Interleukin-10. R. G. Landes Co., Austin, TX.
2. de Waal Malefyt, R., J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915.
3. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444.
4. Koppelman, B., J. J. Neefjes, J. E. de Vries, and R. de Waal Malefyt. 1997. Interleukin-10 down-regulates MHC class II αβ peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 7:861.
5. Chang, C. H., M. Furue, and K. Tamaki. 1994. Selective regulation of ICAM-1 and major histocompatibilily complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells. Eur. J. Immunol. 24:2889.
6. Willems, F., A. Marchant, J. P. Delville, C. Gerard, A. Delvaux, T. Velu, M. de Boer, and M. Goldman. 1994. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur. J. Immunol. 24:1007.
7. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
8. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815.
9. Gazzinelli, R. T., I. P. Oswald, S. L. James, and A. Sher. 1992. IL-10 inhibits parasite killing and nitric oxide production by IFN-γ-activated macrophages. J. Immunol. 148:1792.
10. + T cells. J. Exp. Med. 184:19.
11. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737.
12. Roncarolo, M.-G. 1995. Interleukin-10 and transplantation tolerance. In Interleukin-10. J. de Vries and R. de Waal Malefyt. eds. R.G. Landes, Austin, TX, pp. 113-120.
13. Krenger, W., K. Snyder, S. Smith, and J. L. Ferrara. 1994. Effects of exogenous interleukin-10 in a routine model of graft-versus-host disease to minor histocompatibility antigens. Transplantation 58:1251.
14. Blazar, B. R., P. A. Taylor, S. Smith, and D. A. Vallera. 1995. Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts. Blood 85:842.
15. + T cells. J. Immunol. 160:3188.
16. Kouskoff, V., H. Fehling, M. Lemeur, C. Benoist, and D. Mathis. 1993. A vector driving the expression of foreign cDNAs in the MHC class II-positive cells of transgenic mice. J. Immunol. Methods 166:287.
17. Yssel, H., J. E. de Vries, M. Koken, W. Van Blitterswijk, and H. Spits. 1984. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J. Immunol. Methods 72:219.
18. Abrams, J. S., M. G. Roncarolo, H. Yssel, U. Andersson, G. J. Gleich, and J. E. Silver. 1992. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127:5.
19. Cottrez, F., C. Auriault, A. Capron, and H. Groux. 1994. Quantitative PCR: validation of the use of a multispecific internal control. Nucleic Acids Res. 22:2712.
20. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229.
21. Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober. 1991. Current Protocols in Immunology. John Wiley and sons, New York.
22. Rousset, F., E. Garcia, T. Defrance, C. Peronne, N. Vezzio, D. H. Hsu, R. Kastelein, K. W. Moore, and J. Banchereau. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89:1890.
23. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
24. Uyttenhove, C., J. Maryanski, and T. Boon. 1983. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen loss variants rather than immunosuppression. J. Exp. Med. 157:1040.
25. Kelly, J. P., and G. J. Bancroft. 1996. Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes. Eur. J. Immunol. 26:356.
26. Vieth, M., A. Will, K. Schroppel, M. Rollinghoff, and A. Gessner. 1994. Interleukin-10 inhibits antimicrobial activity against Leishmania major in murine macrophages. Scand. J. Immunol. 40:403.
27. Hagenbaugh, A., S. Sharma, S. M. Dubinett, S. H. Y. Wei, R. Aranda, H. Cheroutre, D. J. Fowell, S. Binder, B. Tsao, R. M. Locksley, K. W. Moore, and M. Kronenberg. 1997. Altered immune responses in interleukin-10 transgenic mice. J. Exp. Med. 185:2101.
28. Bejarano, M. T., R. de Waal Malefyt, J. S. Abrams, M. Bigler, R. Bacchetta, J. E. de Vries, and M.-G. Roncarolo. 1992. Interleukin 10 inhibits allogeneic proliferate and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int. Immunol. 4:1389.
29. Suzuki, T., H. Tahara, S. Narula, K. W. Moore, P. D. Robbins, and M. T. Lotze. 1995. Viral irterleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J. Exp. Med. 182:477.
30. Matsuda, M., F. Salazar, M. Petersson, G. Masucci, J. Hansson, P. Pisa, Q. J. Zhang, M. G. Masucci, and R. Kiessling. 1994. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J. Exp. Med. 180:2371.
31. Chen, W. F., and A. Zlotnik. 1991. IL-10: a novel cytotoxic T cell differentiation factor. J. Immunol. 147:528.
32. Yang, G., K. E. Hellstrom, M. T. Mizuno, and L. Chen. 1995. In vitro priming of tumor-reactive catalytic T lymphocytes by combining IL-10 with B7-CD28 costimulation. J. Immunol. 155:3897.